<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(7)</volume><submitter>Ihle MA</submitter><pubmed_abstract>Aberrantly expressed microRNAs (miRNAs) are involved in many diseases including cancer. In gastrointestinal stromal tumours (GISTs) expression of miR-221 and miR-222 is reduced compared to control tissue and other sarcomas but the functional effects of this downregulation are not fully understood. This study aimed at evaluating the miR-221 and miR-222 expression profiles in different GIST subtypes and the functional role of these miRNAs. Expression of miR-221 and miR-222 was analysed in six KIT exon 9 and three KIT exon 11 mutated and nine wildtype GISTs by qPCR. Viability and apoptosis were examined in three different, KIT positive GIST cell lines (GIST882, GIST-T1 and GIST48) after overexpression of these miRNAs. The modulation of KIT and the PI3K/AKT pathways was determined by Western b</pubmed_abstract><journal>Molecular oncology</journal><pagination>1421-33</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5528808</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.</pubmed_title><pmcid>PMC5528808</pmcid><pubmed_authors>Ihle MA</pubmed_authors><pubmed_authors>Huss S</pubmed_authors><pubmed_authors>Schildhaus HU</pubmed_authors><pubmed_authors>Buettner R</pubmed_authors><pubmed_authors>Wardelmann E</pubmed_authors><pubmed_authors>Fassunke J</pubmed_authors><pubmed_authors>Trautmann M</pubmed_authors><pubmed_authors>Bauer S</pubmed_authors><pubmed_authors>Merkelbach-Bruse S</pubmed_authors><pubmed_authors>Kuenstlinger H</pubmed_authors><pubmed_authors>Heydt C</pubmed_authors></additional><is_claimable>false</is_claimable><name>miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.</name><description>Aberrantly expressed microRNAs (miRNAs) are involved in many diseases including cancer. In gastrointestinal stromal tumours (GISTs) expression of miR-221 and miR-222 is reduced compared to control tissue and other sarcomas but the functional effects of this downregulation are not fully understood. This study aimed at evaluating the miR-221 and miR-222 expression profiles in different GIST subtypes and the functional role of these miRNAs. Expression of miR-221 and miR-222 was analysed in six KIT exon 9 and three KIT exon 11 mutated and nine wildtype GISTs by qPCR. Viability and apoptosis were examined in three different, KIT positive GIST cell lines (GIST882, GIST-T1 and GIST48) after overexpression of these miRNAs. The modulation of KIT and the PI3K/AKT pathways was determined by Western b</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Aug</publication><modification>2025-04-26T08:54:50.546Z</modification><creation>2019-03-27T02:51:44Z</creation></dates><accession>S-EPMC5528808</accession><cross_references><pubmed>25898773</pubmed><doi>10.1016/j.molonc.2015.03.013</doi></cross_references></HashMap>